The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28234966)

Published in PLoS One on February 24, 2017

Authors

Marina A Afanasyeva1, Lidia V Putlyaeva1, Denis E Demin2, Ivan V Kulakovskiy1,3,4, Ilya E Vorontsov3, Marina V Fridman3, Vsevolod J Makeev1,2,3, Dmitry V Kuprash1,2,5, Anton M Schwartz1

Author Affiliations

1: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
2: Moscow Institute of Physics and Technology, Moscow, Russia.
3: Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.
4: Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, Moscow, Russia.
5: Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.

Articles cited by this

The human genome browser at UCSC. Genome Res (2002) 168.23

An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

Common regulatory variation impacts gene expression in a cell type-dependent manner. Science (2009) 11.28

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2011) 11.03

Integrative analysis of 111 reference human epigenomes. Nature (2015) 10.32

An atlas of active enhancers across human cell types and tissues. Nature (2014) 6.57

Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover. Mol Biol Evol (2002) 6.44

Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature (2014) 5.61

Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature (2014) 5.22

Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell (2003) 4.67

Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23

The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A (1990) 3.71

Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet (2011) 3.65

Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet (2009) 3.59

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52

Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity (2010) 3.27

Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum Genet (2008) 2.92

Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis. Sci Transl Med (2012) 2.14

Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol (1989) 2.03

Refining genetic associations in multiple sclerosis. Lancet Neurol (2008) 1.85

is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics (2010) 1.84

Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J Exp Med (1984) 1.84

Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. Biotechniques (1995) 1.66

Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells. J Exp Med (1990) 1.65

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol (2009) 1.55

IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun (2008) 1.43

Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem (1998) 1.32

GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes. Nucleic Acids Res (2014) 1.26

Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol (2011) 1.25

Quantifying the effect of sequence variation on regulatory interactions. Hum Mutat (2010) 1.23

Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett (2009) 1.21

The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol (2008) 1.19

The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. PLoS One (2010) 1.18

Cis and trans effects of human genomic variants on gene expression. PLoS Genet (2014) 1.06

Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Anal Biochem (2005) 1.05

Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells. J Leukoc Biol (2008) 1.03

Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. PLoS One (2013) 1.02

The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunology (1992) 0.99

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis. Ann Clin Transl Neurol (2015) 0.96

HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models. Nucleic Acids Res (2015) 0.95

From binding motifs in ChIP-Seq data to improved models of transcription factor binding sites. J Bioinform Comput Biol (2013) 0.93

Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin Endocrinol (Oxf) (2006) 0.91

Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus. Mol Cell Biol (2001) 0.90

Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun (2009) 0.90

Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Interferon Cytokine Res (2011) 0.90

The Genetics of Transcription Factor DNA Binding Variation. Cell (2016) 0.90

Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis. J Int Med Res (2011) 0.84

Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia. Leuk Lymphoma (2011) 0.83

The expression of functional IL-2 receptor on activated macrophages depends on the stimulus applied. Immunology (1989) 0.82

Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese. J Neurol Sci (2013) 0.81

Progress in multiple sclerosis genetics. Curr Genomics (2012) 0.81

Characterization of MT-2 cells as a human regulatory T cell-like cell line. Cell Mol Immunol (2014) 0.79

Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis. Mult Scler (2015) 0.78

Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells. Biochim Biophys Acta (2016) 0.76

Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA. Mult Scler (2011) 0.76

Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J Endocrinol (2005) 0.76